The emerging clinical relevance of genomic profiling in neuroendocrine tumours

被引:0
作者
Guney Isa Burak
Sonmezler Ozge
Mujde Cem
Buyukdereli Gulgun
Dogruca Yapar Zeynep
Bisgin Atil
机构
[1] Cukurova University Faculty of Medicine Nuclear Medicine Department of Balcali Hospital and Clinics,
[2] Cukurova University AGENTEM (Adana Genetic Diseases Diagnosis and Treatment Center),undefined
[3] Cukurova University AGENTEM & Cukurova University Faculty of Medicine Medical Genetics Department of Balcali Hospital and Clinics,undefined
来源
BMC Cancer | / 21卷
关键词
Neuroendocrine tumours; Next generation sequencing; Genomic profiling; Somatic mutation; Liquid biopsy; Circulating cell-free DNA;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 66 条
[1]  
Oronsky B(2017)Nothing But NET: a review of neuroendocrine tumors and carcinomas Neoplasia. 19 991-1002
[2]  
Ma PC(2018)NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2.2018 J Natl Compr Cancer Netw 16 693-702
[3]  
Morgensztern D(2010)Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin Endocr Relat Cancer 17 R75-R90
[4]  
Carter CA(2018)A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal Mod Pathol 31 1770-1786
[5]  
Shah MH(2018)Genomic landscape of pancreatic neuroendocrine tumours: the international Cancer genome consortium J Endocrinol 236 R161-R1r7
[6]  
Goldner WS(2019)Current best practice in the management of neuroendocrine tumors Ther Adv Endocrinol Metab 10 2042018818804698-570
[7]  
Halfdanarson TR(2016)Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a fox Chase Cancer Center pilot study Br J Cancer 115 564-536
[8]  
Bergsland E(2019)Genetics and epigenetics of Gastroenteropancreatic neuroendocrine neoplasms Endocr Rev 40 506-2508
[9]  
Berlin JD(2013)The genomic landscape of small intestine neuroendocrine tumors J Clin Invest 123 2502-2124
[10]  
Halperin D(2014)Profiling of 1,350 neuroendocrine tumors for identification of multiple potential drug targets J Clin Oncol 32 4113-3599